This invention is directed to compounds of the formula (I):
and their pharmaceutically acceptable salts, wherein R
1
, R
2
, R
3
and Z are as defined herein; intermediates for the synthesis of such compounds, pharmaceutical compositions containing such compounds; and methods of using such compounds in the treatment of neurological and psychological disorders.